;

Auto Summaries - Immunology
Last updated: 2025 Jul 18
Total hit(s): 28283
S.No.
1
39957551
Reply to the letter to the editor: previous immunological disease can promote neurological complications of SARS-CoV-2 infection, such as VST or GBS.
N/A
Future Sci OA
2025 Dec
3.25
1
2
39794268
Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia.
N/A
Expert Rev Vaccines
2025 Dec
4.37
1
3
39927642
Previous immunological disease can promote neurological complications of SARS-CoV-2 infection, such as VST or GBS.
N/A
Future Sci OA
2025 Dec
3.25
1
4
40632988
An Evidence-Based Approach to Covid-19 Vaccination. Reply.
N/A
N Engl J Med
2025 Jul 9
37.91
1
5
40632985
An Evidence-Based Approach to Covid-19 Vaccination.
N/A
N Engl J Med
2025 Jul 9
37.91
1
6
40632984
An Evidence-Based Approach to Covid-19 Vaccination.
N/A
N Engl J Med
2025 Jul 9
37.91
1
7
40632983
An Evidence-Based Approach to Covid-19 Vaccination.
N/A
N Engl J Med
2025 Jul 9
37.91
1
8
40632986
An Evidence-Based Approach to Covid-19 Vaccination.
N/A
N Engl J Med
2025 Jul 9
37.91
1
9
40632987
An Evidence-Based Approach to Covid-19 Vaccination.
N/A
N Engl J Med
2025 Jul 9
37.91
1
10
40638836
The Heterogenous Presentations of De Novo and Recurrent Ocular Inflammation following COVID-19 Vaccination: A Multicenter Report and Review of the Literature.
N/A
Retina
2025 Jul 8
6.7
1
11
40628443
Covid-19: Indian health ministry refutes links between sudden cardiac death and vaccination.
N/A
BMJ
2025 Jul 8
30.22
1
12
40619244
Erratum: "Coffee and green tea consumption with the risk of COVID-19 among the vaccine recipients in Japan: a prospective study" [J Epidemiol 34(9) (2024) 444-452].
N/A
J Epidemiol
2025 Jul 5
5.8
1
13
40610940
Correction: Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE).
N/A
BMC Infect Dis
2025 Jul 3
2.58
1
14
40651020
COVID-19 update: mNEXSPIKE - a new Moderna mRNA vaccine for COVID-19.
N/A
Med Lett Drugs Ther
2025 Jul 21
0.8
1
15
40651018
COVID-19 update: Full approval for Novavax COVID-19 vaccine.
N/A
Med Lett Drugs Ther
2025 Jul 21
0.8
1
16
40562032
Improved SARS-CoV-2 vaccine based on intranasally administered replicon RNA.
N/A
Mol Ther
2025 Jul 2
17
1
17
40671410
Correspondence on "Evaluating University and Surrounding Area Factors Causing Variability in COVID-19 Vaccine Rates Among United States Universities".
N/A
Disaster Med Public Health Prep
2025 Jul 17
0.94
1
18
40659940
Correction: A case of autosomal dominant polycystic kidney disease with systemic lupus erythematosus developing after SARSCoV2 vaccination.
N/A
CEN Case Rep
2025 Jul 15
1.5
1
19
40669667
Mucous Membrane Pemphigoid After SARS-CoV-2 Vaccine.
N/A
Actas Dermosifiliogr
2025 Jul 14
0.5
1
20
40652681
Corrigendum to "Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey" [Vaccine 41(41) (2023) 6120-6126].
N/A
Vaccine
2025 Jul 11
3.31
1
21
40640175
Author Correction: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters.
N/A
NPJ Vaccines
2025 Jul 10
4.98
1
22
40597080
Matters Arising: Safety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort study: methodological biases in study design with potential impact on the study's interpretation.
N/A
BMC Pregnancy Childbirth
2025 Jul 1
2.65
1
23
40596903
Reply to matters arising: Safety of SARS-CoV-2 vaccination during pregnancy - obstetric outcomes from a large cohort study: methodological biases in study design with potential impact on the study's interpretation.
N/A
BMC Pregnancy Childbirth
2025 Jul 1
2.65
1
24
40668543
Comment on "Persistence of a High Seroconversion Rate 3.2 0.13 Years After Last COVID-19 Vaccination in Heart Transplant Recipients".
N/A
Clin Transplant
2025 Jul
1.63
1
25
40575989
Adverse Events After COVID-19 Vaccination Between Pregnant and Nonpregnant Women.
N/A
Birth Defects Res
2025 Jul
1.83
1